As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
North America is expected to hold a significant share in the overall market growth of primary cells. This can be attributed to the increasing applications of primary cells in the stem cell therapy for tissue regeneration for the treatment of cancers, spinal cord injuries, and other immunodeficiency disorders. In addition to this, the growth in the region is majorly driven by huge investments into research and development (R&D) and the growth of the healthcare sector in the region. Moreover, the growth in the regional market can also be attributed to the presence of leading biopharmaceutical companies in the region, which effectively utilise primary human and animal cells for the production of vaccines against diseases like rabies, chickenpox, and polio, among others. Further, the COVID-19 pandemic also accelerated the pharmaceutical and biotechnology-based research projects, which also included the development of cell therapy driven by primary cells, hence further stimulating the market growth in the region.
In March 2021, Axol Bioscience Ltd., a global leader in the market for primary cells, recently announced a merger with Censo Biotechnologies. The merged company is focused on providing product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Further, it will offer validated ready-to-use cell lines to its customers along with expert services, robust functional data, and customisation capabilities in short time. Such expansion projects undertaken by leading market players are augmenting the overall market for primary cells. The market is further augmented by the developments made by the leading players in the market, including Lonza Group AG. (SWX: LONN).
Market Analysis by Origin, Cell Type, End User, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global primary cells market are Merck KGaA, Axol Bioscience Ltd., Cell Biologics, Inc., Lonza Group AG., and PromoCell GmbH, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.